Dhavendra Kumar on Personalised & Evidence-Based Medicine

August 2016 15 minutes English

Interview with Dhavendra Kumar, Consultant in Clinical Genetics, Institute of Cancer & Genetics, Cardiff University School of Medicine

At ECRIN's International Clinical Trials Day (ICTD) 2016 meeting in Prague, Czech Republic, Dhavendra Kumar responded to the following:

  • What is the definition of personalised medicine and evidence-based medicine, and what do they mean in relation to clinical trials?
  • What is the potential impact of evidence-based medicine on public health?